Co-clinical study of [fam-] trastuzumab deruxtecan (DS8201a) in patient-derived xenograft models of uterine carcinosarcoma and its association with clinical efficacy.
Co-clinical study of [fam-] trastuzumab deruxtecan (DS8201a) in patient-derived xenograft models of uterine carcinosarcoma and its association with clinical efficacy.
复制标题
[fam-]曲妥珠单抗 deruxtecan (DS8201a) 在患者来源的子宫癌肉瘤异种移植模型中的联合临床研究及其与临床疗效的关系。
DOI：
--
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Hamada A.
中科院分区：
文献类型：
--
作者：
Yagishita S;Nishikawa T;Yoshida H;Shintani D;Sato S;Miwa M;Suzuki M;Yasuda M;Ogitani Y;Jikoh T;Yonemori K;Hasegawa K;Hamada A.
